SUMMARY
Downregulation of the miR-143/145 microRNA (miRNA) cluster has been repeatedly reported in colon cancer and other epithelial tumors. In addition, overexpression of these miRNAs inhibits tumorigenesis, leading to broad consensus that they function as cell-autonomous epithelial tumor suppressors. We generated mice with deletion of miR-143/145 to investigate the functions of these miRNAs in intestinal physiology and disease in vivo. Although intestinal development proceeded normally in the absence of these miRNAs, epithelial regeneration after injury was dramatically impaired. Surprisingly, we found that miR-143/145 are expressed and function exclusively within the mesenchymal compartment of intestine. Defective epithelial regeneration in miR-143/145-deficient mice resulted from the dysfunction of smooth muscle and myofibroblasts and was associated with derepression of the miR-143 target Igfbp5, which impaired IGF signaling after epithelial injury. These results provide important insights into the regulation of epithelial wound healing and argue against a cell-autonomous tumor suppressor role for miR-143/145 in colon cancer.
INTRODUCTION
MicroRNAs (miRNAs) represent a broad class of 18-22 nucleotide RNAs that negatively regulate the stability and translation of target messenger RNAs. Although initially identified more than 2 decades ago as developmental regulators in invertebrates (Lee et al., 1993; Reinhart et al., 2000; Wightman et al., 1993) , subsequent evaluation of numerous miRNAs in worms, flies, and mice has demonstrated that these transcripts rarely provide essential functions during animal development (Miska et al., 2007; van Rooij et al., 2007) . Instead, miRNA deletion has repeatedly been associated with latent pathological defects exposed only upon stressing or taxing an organ system (Leung and Sharp, 2010; Mendell and Olson, 2012) . These experimental findings have led to the suggestion that mammalian miRNAs commonly function in vivo to buffer cells and tissues against stressors and thereby maintain homeostasis.
In keeping with their roles in stress-activated pathways, miRNAs have repeatedly emerged as important diagnostic markers and therapeutic targets in human disease states. A particularly important role for miRNAs in cancer pathogenesis has been uncovered through the examination of human tumor samples. Virtually all examined tumor types are characterized by globally abnormal miRNA expression patterns and profiles of miRNA expression are highly informative for tumor classification, prognosis, and response to therapy (Kong et al., 2012; Lu et al., 2005; Lujambio and Lowe, 2012) . Moreover, numerous reports have documented a functional contribution of specific miRNAs to cellular transformation and tumorigenesis (He et al., 2005; Medina et al., 2010) . Among the first reported examples of abnormal miRNA expression in human cancer was downregulation of miR-143 and miR-145, two cotranscribed miRNAs, in human colorectal adenocarcinoma (Michael et al., 2003) . This observation has been reproduced in numerous subsequent studies (Bandré s et al., 2006; Motoyama et al., 2009; Schepeler et al., 2008; Slaby et al., 2007) , and similar findings have been reported in breast cancer, pancreatic cancer, and other solid tumors of epithelial origin (Iorio et al., 2005; Papaconstantinou et al., 2013; Takagi et al., 2009 ). In addition, functional studies have demonstrated that ectopic expression of these miRNAs inhibits proliferation, induces apoptosis, and/or suppresses anchorage-independent growth and tumor-forming ability of diverse cancer cell types in vitro and in vivo (Chen et al., 2009; Clapé et al., 2009; Kent et al., 2010; Sachdeva et al., 2009) . These effects are mediated, at least in part, by the direct repression of oncogenes such as MYC and KRAS. Based on these data, it is broadly accepted that miR-143/145 function as cell-autonomous tumor suppressors in colon cancer and other epithelial tumor types. Nevertheless, the natural functions of miR-143/145 in the mammalian intestine and other epithelial tissues that underlie their presumed tumor suppressor activity have not been investigated.
The intestine is unique among mammalian tissues in the rate and number of ongoing mitotic divisions it requires for homeostasis. The rapid turnover of the intestinal epithelium depends on the presence of renewing stem cells that can provide a continuous supply of epithelial cells under basal conditions as well as additional cells to re-establish the epithelial barrier after mucosal injury (Barker et al., 2007; Sangiorgi and Capecchi, 2008; Takeda et al., 2011; Tian et al., 2011; Yan et al., 2012) . The delicate balance between self-renewal and differentiation, as well as robust responses to various insults, relies both on intrinsic epithelial mechanisms and extrinsic signals from several sources, including local mesenchymal cells and immune cells. Among the most important regulators of the intestinal epithelium are pericryptal mesenchymal cells, sometimes referred to as intestinal subepithelial myofibroblasts (ISEMFs), which occupy a position just below the basement membrane of the epithelium. ISEMFs provide important paracrine regulatory signals to intestinal epithelial cells during normal physiologic turnover and in the setting of wound repair (Madison et al., 2005; Otte et al., 2003; Powell et al., 2011; Shao et al., 2006 ). The precise origin of these cells is ill defined, but may include activation of resident fibroblasts, dedifferentiation of local smooth muscle cells, or even migration of bone marrow resident progenitors (Powell et al., 2011) . A comprehensive understanding of the mechanisms that regulate myofibroblast behavior after injury and the paracrine factors that these and other stromal cells secrete to regulate epithelial proliferation and repair is of broad interest because it may allow the co-option of these pathways for therapeutic benefit.
To better understand the functions of miR-143/145 in intestinal physiology and disease in vivo, we generated mice with constitutional or tissue-restricted deletion of these miRNAs. While miR-143/145 loss-of-function had no overt effect on intestinal development, we uncovered an essential role for these miRNAs in the epithelial regenerative response induced by intestinal injury. Surprisingly, this phenotype was entirely attributable to a mesenchymal function, as demonstrated by a complete absence of miR-143/145 expression in the intestinal epithelium and lineage-specific deletion studies. Furthermore, we provide evidence that the observed defect in epithelial regeneration is mediated by aberrant paracrine signaling by smooth muscle and myofibroblasts. These findings provide important insight into the functions of miR-143/145 in intestinal physiology and tumorigenesis and contribute to our understanding of the mechanisms that govern epithelial repair in this tissue. Figures 1A and S1B ). As reported elsewhere, germline deletion of these miRNAs resulted in no overt developmental defects and the targeted alleles were transmitted at the expected Mendelian ratios (data not shown) (Boettger et al., 2009; Xin et al., 2009 To assess whether a latent stress-induced defect exists in the intestines of miR -/-mice, we administered dextran sulfate sodium (DSS), which induces a well-tolerated epithelial injury-regeneration sequence in wild-type animals (Clapper et al., 2007) . Following 5 days of DSS administration via drinking water, control mice exhibited transient weight loss and severe acute colitis, leaving patches of completely de-epithelialized mucosa ( Figures  S3A and S3B ). This was followed by a robust regenerative response, evident by 2 days after removal of DSS (experimental day 5+2, hereafter referred to as D5+2), characterized by the presence of elongated, hyperproliferative crypts in ulcer-adjacent areas that stained positively for Ki67 and phosphorylated histone H3 (pH3, a mitotic marker) throughout their lengths, but lacked differentiated goblet cells ( Figure 1C ). Near complete restoration of the intestinal mucosal architecture was achieved by 9 days after DSS injury (data not shown). Surprisingly, when miR -/-animals were subjected to the identical DSS treatment, a majority succumbed to fulminant disease by D5+2 ( Figure 1D ). Grossly, the colons of these animals uniformly appeared distended, hemorrhagic, and necrotic ( Figure 1E ). The mortality of miR -/-mice following exposure to DSS could result from more extensive epithelial injury or a failure to regenerate the damaged epithelium. Weight loss of wild-type and knockout mice after DSS treatment was indistinguishable, suggesting equivalent injury ( Figure S3A ). Similarly, histologic evidence of tissue injury and apoptosis on experimental day 5 were comparable between miR +/+ and miR -/-animals (Figure S3B ). However, despite the similar appearance of wildtype and knockout colons immediately after exposure to DSS, miR -/-mice exhibited a striking deficiency of regenerating crypts after injury (D5+2) ( Figure 1C ). In miR -/-mice, ulcer-adjacent crypts remained exclusively in the nonregenerative state with numerous goblet cells and proliferation limited to the base. Together, these data indicate that mortality following DSS treatment in miR -/-mice is specifically attributable to a failure of the intestinal epithelium to mount a regenerative response following injury.
RESULTS

Normal
miR-143/145 Are Exclusively Expressed in the Intestinal Mesenchyme
The regenerative failure in miR -/-mice could result either from an intrinsic epithelial proliferative defect or from a non-cell-autonomous abnormality in a supporting cell population that produces one or more critical paracrine factors. In order to distinguish between these possibilities, we first examined the miR-143/145 expression domain in mouse colon using in situ hybridization (ISH) (Figures 2A and 2B ). Robust miR-143/145 expression was detected in the mesenchymal cells of the intestine, especially in smooth muscle cells as reported elsewhere (Boettger et al., 2009; Xin et al., 2009) and in pericryptal cells located in a position consistent with lamina propria myofibroblasts. In contrast, expression of these miRNAs was not detectable within intestinal epithelial cells, contrary to some previously reported ISH studies (Zhu et al., 2011) . Because these data were at odds with a large body of published literature that implicates miR-143/145 as cell-autonomous tumor suppressors in the intestine, we measured miRNA expression in purified epithelial cells using a more sensitive quantitative reverse transcription PCR (qRT-PCR) assay. Consistent with our ISH findings, miR-143 and miR-145 were easily detectable in whole colon but nearly undetectable by PCR in mouse (Figure 2C) and human ( Figure 2D ) epithelial preparations. We also considered the possibility that miR-143/145 might be selectively induced in epithelial cells following injury, but crypt isolation during and after DSS treatment revealed an identical nonepithelial expression pattern at all time points ( Figure S4A ). , miR +/-, and miR -/-mice, administered 3.5% DSS in drinking water for 5 days. *p < 0.0001, log rank test.
(E) miR +/+ and miR -/-animals necropsied 2 days after completion of DSS treatment. Images are representative of over 20 mice examined per genotype.
See also Figures S1, S2, and S3.
A low level of amplification of miR-143/145 in purified epithelium was most likely due to residual contaminating mesenchymal cells in these preparations. To address this possibility directly, we took advantage of our conditional miR flox allele, which can be deleted in specific lineages using appropriate Cre driver lines. Previously characterized Villin-Cre (Madison et al., 2002) and Twist2 +/Cre (Geske et al., 2008; So si c et al., 2003) mice were obtained and crossed to miR flox animals. The Villin-Cre transgene directs recombination in all cells of the GI tract epithelium, whereas the Twist2 Cre allele drives Cre expression in early mesenchymal cells but, importantly, spares bone marrow cells . We confirmed the specificity of both Cre lines by crossing to ROSA26 LSL-LacZ reporter mice ( Figure 3A ) and directly examining recombination of the miR-143/145 locus in small and large intestine ( Figure S5A ). Additionally, a low level of recombination in total bone marrow cells, hematopoietic stem cells, and major hematopoietic lineages was confirmed in Twist2 Cre/+ ; miR flox/flox animals ( Figure S5B ). miR-143 and miR-145 levels in whole colon were unchanged in Villin-Cre; miRflox/flox animals compared to control littermates, indicating that the detectable miR-143/145 expression in this tissue does not derive from the epithelial compartment ( Figure S5C ). In contrast, Twist2 in purified epithelium, supporting a mesenchymal-restricted expression domain. We further considered the possibility that miR-143/145 might be expressed exclusively in rare intestinal stem cells (ISCs) and that analysis of bulk epithelial preparations might therefore be insufficiently sensitive to detect them. Fluorescence-activated cell sorting (FACS) was used to purify ISCs from Lgr5 +/eGFP mice (Barker et al., 2007) , revealing undetectable levels of miR-143/145 in this epithelial-derived population ( Figure 2E ). On the contrary, miR-143/145 were readily expressed in primary intestinal subepithelial myofibroblasts (ISEMFs) isolated from newborn mouse colon (Shaker et al., 2010) . Collectively, the data from ISH, purified epithelial preparations, sorted ISCs, and cultured ISEMFs conclusively demonstrate that miR-143/ 145 expression is restricted to the intestinal mesenchyme in human and mouse. (D) Proliferation of ulcer-adjacent crypts assessed by H&E (top), Ki67, and pH3 staining. Histology (H&E) was examined in five to ten mice of each genotype, while a subset of sections (n R 3) were further stained for Ki67 and pH3.
(E) Quantification of the average number of pH3+ cells within 500 mm of de-epthelialized zones. Multiple ulcer-adjacent areas in at least three mice per genotype were quantified. **p < 0.01 (Student's t test). See also Figure S5 .
mesenchymal cells in tumors relative to normal mucosal biopsies typically used as a basis of comparison. To examine this possibility, we obtained biopsies of human colorectal cancers and paired normal colon and measured miR-143/145 levels in the unfractionated tissue as well as in purified epithelium. As reported, miR-143/145 levels were significantly lower in whole tumors compared to whole colon samples ( Figure 2D ). miR-143/145 in purified epithelial cells from the same biopsies, however, were detectable only at background levels. Thus, the reduced levels of these miRNAs that is observed when comparing tumors to normal tissue is not due to their downregulation in tumor epithelial cells. Lastly, we addressed the possibility that miR-143/145 are induced in intestinal epithelium as a protective mechanism against transformation following an initial oncogenic hit and then later silenced as tumorigenesis progresses. Among the earliest and most common oncogenic lesions in colorectal cancer is loss of the APC tumor suppressor gene and consequent constitutive activation of the Wnt/b-catenin pathway. Apc min/+ mice harbor a heterozygous truncating mutation in Apc and, as a result, develop numerous intestinal adenomas due to biallelic Apc loss-of-function (Haigis et al., 2002; Lamlum et al., 2000) . As observed in human tumors, whole Apc min adenomas exhibit lower levels of miR-143/145 compared to wild-type intestine ( Figure S4B ). Importantly, levels of miR-143/145 remain at background levels in purified epithelial cells from these adenomas. Thus, although it remains formally possible that other oncogenic pathways activate expression of these miRNAs in epithelial cells, this is not a feature of the Wnt/b-catenin pathway that is hyperactive in the majority of human colorectal cancers.
Mesenchymal, but Not Epithelial, miR-143/145 Deletion Phenocopies Germline Deletion Despite the extensive evidence that miR-143/145 expression is absent in the intestinal epithelial compartment, it remained formally possible that levels of these miRNAs below the limit of detection were sufficient to support a function within epithelial cells. Figure 3B) and histologic evidence of robust epithelial regeneration was present including numerous elongated, hyperproliferative crypts flanking ulcerated areas ( Figure 3D Figures  3D and 3E ). We conclude from these results that the functions of these miRNAs are exclusively performed within the mesenchymal compartment of the intestine.
Evidence for Smooth Muscle and Myofibroblast Dysfunction in miR-143/145 -/-Mice
A role for smooth muscle in the regulation of intestinal epithelial regeneration has not previously been documented. Yet given the prominent smooth muscle expression of miR-143/145 as reported elsewhere (Boettger et al., 2009; Xin et al., 2009 ) and confirmed by our ISH studies (Figure 2A) , we sought to determine whether dysfunction of this cell type underlies the regenerative failure in miR -/-mice. To this end, miR flox mice were crossed to transgenic Myh11-Cre/eGFP mice (Xin et al., 2002) , which direct Cre and eGFP expression under the control of the murine smooth muscle myosin heavy chain (smMHC) promoter. In colon tissues from these mice, transgene expression was restricted to the muscularis propria, muscularis mucosae, and rare lamina propria cells (see Figure 5D ). In addition to smooth muscle, ISH documented strong expression of miR-143/145 in pericryptal cells of the lamina propria, located in a position consistent with intestinal subepithelial myofibroblasts (ISEMFs) ( Figure 2B ). Accordingly, we observed robust miR-143/145 expression in cultured primary ISEMFs ( Figure 2E ). Given that myofibroblasts are known to act as major regulators of epithelial cell proliferation in normal physiology and during wound repair (Powell et al., 2011) , we hypothesized that dysfunction of this cell type contributed to regenerative failure in miR -/-mice. The morphology of lamina propria myofibroblasts was identical in miR +/+ and miR -/-colons prior to DSS treatment, as documented by smooth muscle actin (SMA) staining (Figure 5A ). After injury, myofibroblasts in wild-type colons upregulated SMA and underwent a dramatic reorganization within ulcerated zones, adopting an elongated configuration with highly parallel basal-luminal orientation ( Figure 5B Figure 5C ). To our surprise, we also observed morphologically abnormal myofibroblasts in the ulcerated regions of Myh11-Cre/eGFP; miR -/flox colons, despite restriction of Cre expression to smooth muscle. Importantly, the presence of the Villin-Cre, Twist2
Cre , and Myh11-Cre/GFP alleles alone did not result in myofibroblast disorganization after injury ( Figure S6B ). Thus, in every assayed genotype, regenerative failure was associated with abnormal myofibroblast morphology, suggesting a role for this cell type in the miR -/-DSS phenotype.
Smooth Muscle Gives Rise to a Population of Lamina Propria Myofibroblasts following Colonic Epithelial Injury
The precise origin of the organized myofibroblasts in ulcers of wild-type mice after DSS injury is unclear, as they have not been reported previously. In other settings, myofibroblasts have been reported to arise from pre-existing myofibroblasts, activated fibroblasts, smooth muscle cells, and even bone marrow-derived cells (Powell et al., 2011) . Given the surprising finding that smooth muscle ablation of miR-143/145 led to abnormal myofibroblasts in the lamina propria, we tested whether myofibroblasts in DSS ulcers are derived from smooth muscle. Myh11-Cre/eGFP; Rosa26 mTmG/+ mice (Muzumdar et al., 2007) were generated in order to label smooth muscle cells and their descendants with permanent GFP expression, even after inactivation of the Myh11 promoter. Indeed, we found a significant number of smooth muscle-derived lamina propria cells present within DSS-induced ulcers ( Figure 5D ). All the GFP+ cells coexpressed SMA ( Figure S6C ), consistent with a myofibroblast identity. Interestingly, a subset of myofibroblasts did not express GFP, suggesting that these cells arise from preexisting myofibroblasts or other nonsmooth muscle lineages. Taken together, these results support a model whereby smooth muscle and other mesenchymal lineages contribute to the myofibroblast pool, which in turn regulates epithelial regeneration following injury. type contributes to the observed regenerative failure. We hypothesized that dysregulation of one or more critical paracrine signaling molecules produced by these cells contributes to the DSS phenotype. (Table S1 ), which is predicted to be a target of miR-143 by the Targetscan algorithm (Friedman et al., 2009) . IGFBP5 is a secreted negative regulator of IGF signaling that binds and sequesters IGF ligands (Pollak, 2008) . IGF signaling, in turn, is known to stimulate intestinal epithelial proliferation and promotes recovery after DSS treatment (Howarth et al., 1998) . qRT-PCR validated the upregulation of Igfbp5 in miR -/-ISEMFs and, notably, in whole colons exclusively after DSS injury ( Figure 6A ). Although no other predicted miR-143/145 targets were upregulated >2-fold in miR -/-ISEMFs, microarray analysis did reveal upregulation of Bone morphogenic protein 4 (Bmp4), a known inhibitor of intestinal epithelial proliferation (He et al., 2004) , and Insulin-like growth factor binding protein 4 (Igfbp4), a negative regulator of both the IGF and Wnt pathways (Zhu et al., 2008) (Table S1 ). While qRT-PCR validated the upregulation of these transcripts in ISEMFs (Figure S7A ), they were not differentially expressed in healthy or DSS-injured miR +/+ and miR -/-colons ( Figure S7B ) and therefore were not studied further.
Derepression of
To further investigate the role of Igfbp5 in the regenerative failure characteristic of miR -/-mice, we next validated the direct regulation of this transcript by miR-143. Reporter assays, in which the highly conserved predicted miR-143 binding sites from the human and mouse 3 0 UTRs of Igfbp5 ( Figure 6B ) were cloned downstream of luciferase, demonstrated that these sequences are sufficient to confer direct repression by this miRNA ( Figure 6C ). Colonic Igfbp5 expression was then directly assessed by ISH before and after DSS injury. Irrespective of genotype, Igfbp5 was minimally expressed under basal conditions and in histologically uninjured regions of colon after DSS treatment ( Figure 6D, upper panels) . In injured wild-type colons, ISH revealed detectable but modest induction of Igfbp5 in the lamina propria, muscularis mucosae and muscularis propria specifically in ulcerated regions of the colon. In miR -/-animals, however, Igfbp5 was dramatically upregulated within these domains, consistent with the quantitative RT-PCR (qRT-PCR) data and confirming robust derepression of this target in the absence of miR-143/145 in vivo. The high concentration of IGFBP5 in ulcerated regions of miR -/-colons would be predicted to compete strongly for soluble IGF ligand. Indeed, we observed dramatically reduced IGF1 receptor (IGF1R) activation on the basolateral membranes of ulcer-adjacent crypts in miR -/-mice, as revealed by staining for the phosphorylated receptor ( Figure 6E ). miR-143/145 deletion therefore directly derepressed Igfbp5 expression in vitro and in vivo, resulting in impaired IGF signaling which likely contributed to regenerative failure after DSS-mediated injury.
DISCUSSION
Our in vivo analyses of miR-143/145 functions in intestinal biology have yielded several surprising findings. First, loss of miR-143/145 causes a profound defect in intestinal epithelial regeneration. Second, lineage-specific deletion establishes that this phenotype is entirely attributable to mesenchymal, rather than epithelial, loss of function. Third, miR-143/145 are expressed solely in the mesenchymal cells of the intestine and, therefore, are unlikely to execute cell-autonomous epithelial functions as previously proposed. Last, we present evidence that the observed phenotype is associated with myofibroblast-dependent paracrine inhibition of the IGF signaling pathway. Together, these data establish a role for miR-143/ 145 in intestinal homeostasis and implicate smooth musclederived cells as critical regulators of intestinal regeneration in the mouse. These results have clear implications for the functions of miR-143/145 in intestinal physiology and disease. These miRNAs, owing to their mesenchymal-restricted expression domain, clearly do not function as cell-autonomous regulators of epithelial proliferation, nor are they likely to function as cell-autonomous tumor suppressors in intestinal cancers. Importantly, despite recent reports from the study of other tissues (Hergenreider et al., 2012) , we find no evidence of transfer of mature miR-143 or miR-145 from mesenchymal cells to epithelial cells, as this scenario would result in detectable levels of the mature miRNAs in recipient cells. Moreover, although downregulation of miR-143/145 in colorectal tumors was one of the earliest, and since most reproduced, observations of abnormal miRNA expression in cancer, our data argue that these findings were confounded by sampling bias during tissue isolation. Because tumor samples are depleted in smooth muscle and mesenchyme compared to mucosal biopsies, tumor specimens could artifactually appear to have downregulated miR-143/145 levels when compared to normal tissue. Indeed, by purifying epithelial cells from a set of tumors that appeared to exhibit miR-143/145 downregulation, we showed that the miRNAs are not expressed in the normal or tumor epithelial compartment and thus are not downregulated in the cancer cells themselves. We further demonstrated that an early, common oncogenic lesion in colorectal cancer, loss of the Apc gene, does not result in an induction of miR-143/145 in epithelial cells. Although it remains formally possible that other oncogenic pathways result in de novo activation of miR-143/145 expression in tumor cells, this scenario is not supported by existing data. Of note, our data do not contradict the potent antitumor activities that these miRNAs have been shown to exhibit upon enforced ectopic expression in epithelial cancer cells. Indeed, the expression of developmental lineage ''inappropriate'' miRNAs might represent a therapeutic avenue deserving of further study.
In addition to their potential role as tumor suppressors, miR-143/145 have been extensively studied in the context of vascular smooth muscle biology. A large number of reports have documented abundant expression of miR-143/145 in vascular smooth muscle cells (VSMCs) and have demonstrated a functional role for these miRNAs in the phenotypic responses of VSMCs to blood vessel injury (Boettger et al., 2009; Cheng et al., 2009; Cordes et al., 2009; Xin et al., 2009 ). In the setting of vascular injury, smooth muscle cells undergo phenotypic switching from a contractile to a migratory and secretory state, after which they contribute to neointima formation. Our analyses of myofibroblast origin and function after intestinal injury have revealed interesting parallels to the vasculature. We have shown that, during wound healing, intestinal smooth muscle gives rise to a population of myofibroblasts that migrate into the lamina propria where they may be optimally positioned to signal to regenerating epithelial cells. Indeed, the muscularis mucosa, a classic histologic structure which has been historically assumed to exclusively provide contractile functions during digestion such as villus movement and microperistalsis, is ideally located to provide a reservoir of myofibroblasts available for mobilization after injury and may itself act as a source of paracrine signals. Once activated, myofibroblasts, and possibly smooth muscle cells within the muscularis mucosa, secrete an array of factors that promote re-epithelialization including Wnt ligands, prostaglandin E2 (PGE 2 ), and cytokines such as IL-6 (Andoh et al., 2007; Powell et al., 2011) .
A role for miR-143/145 in the regulation of smooth muscle and myofibroblast-derived paracrine signaling has not previously been demonstrated in mammals. A related function, however, has been proposed for miR-145 in the zebrafish gut where this miRNA indirectly regulates intestinal smooth muscle secretion of BMP4 and is therefore essential for normal epithelial morphogenesis during embryonic development (Zeng and Childs, 2012) . This function is clearly divergent from functions of miR-143/145 in mouse where, as shown here, deletion of these miRNAs is compatible with normal intestinal development and does not affect BMP4 expression ( Figure S7B ) nor BMP signaling at baseline or after injury, as assessed by pSMAD1/5/8 staining of intestinal epithelium (data not shown). Thus, in different vertebrate species, miR-143/145 appears to regulate distinct aspects of smooth muscle physiology.
We identified and validated one likely contributor to the intestinal regenerative defect of miR-143/145-deficient mice in the IGF binding protein IGFBP5. IGF signaling is recognized as a potent stimulant for intestinal growth and repair in a variety of settings, including glucocorticoid treatment, intestinal resection, radiation injury, and DSS colitis (Howarth et al., 1998) . IGF binding proteins (IGFBPs) typically function to competitively inhibit IGF signaling and, accordingly, decreased phosphorylation of epithelial IGF1R was observed in miR-143/145 -/-mice. These findings suggest a model in which Igfbp5 derepression in smooth muscle and myofibroblasts within zones of intestinal injury results in a net decrease in regeneration-promoting IGF signaling (Figure 7) . Nevertheless, future studies will be necessary to determine the consequences of loss of function of Igfbp5 in the context of miR-143/145 deletion to definitively establish the necessity of the IGFBP5-IGF axis in this phenotype.
Given the diversity of pathways that participate in intestinal epithelial regeneration, Igfbp5 derepression is likely only one component of the perturbed signaling milieu generated by miR-143/145 deletion. In addition, it is possible that the morphologic abnormalities of miR-143/145 -/-myofibroblasts directly contribute to a signaling deficiency. Dynamic regulation of stromal cell positioning in the lamina propria after DSS-mediated injury has been shown to stimulate regeneration via more efficient delivery of paracrine secreted factors to epithelial cells (Brown et al., 2007) . It is therefore plausible that the myofibroblast disorganization characteristic of knockout animals reduces effective communication with regenerating cells. Taken together, our observations support a multifaceted contribution of structural and functional abnormalities of smooth muscle and myofibroblasts to regenerative failure in miR-143/145-deficient mice. Elucidation of the full complement of targets of these miRNAs that are responsible for these effects will provide further insight into the control of mammalian epithelial repair by the mesenchyme and uncover novel therapeutic strategies for human diseases related to epithelial proliferative dysfunction. 
DSS Treatment
Mice were treated with 3.5% w/v dextran sulfate sodium (DSS) of molecular weight 36,000-50,000 (MP Biochemicals) in drinking water for 5 days. Solutions of DSS were prepared in autoclaved tap water and passed through 0.45 mm cellulose acetate filters.
Histology, Immunofluorescence, and Immunohistochemistry
Intestinal segments were dissected, flushed with ice-cold saline, and opened longitudinally. Samples were fixed for 24 hr in 10% neutral buffered formalin and wrapped into ''Swiss rolls'' before standard tissue processing and sectioning. Routine H&E staining was performed for general histology. Immunostaining was performed as previously described (Shi et al., 2009 ).
Isolation of Intestinal Crypts
Mouse and human crypts were isolated as previously described (Sato et al., 2009 ) with minor modifications (see Supplemental Information).
Isolation and Culture of ISEMFs
ISEMFs were isolated as previously described (Shaker et al., 2010) and maintained in high glucose DMEM media supplemented with 10% fetal bovine serum (Invitrogen), 13 ITS supplement (Sigma), and 13 Antibiotic/Antimycotic (Invitrogen). Treatment with 1 mg/ml LPS (Sigma) for 24 hr was used for microarray and qRT-PCR experiments.
In Situ Hybridization
In situ hybridization detection of miRNAs was performed using the miRCURY LNA miRNA ISH Kit (Exiqon), with slight modifications to the manufacturer's protocol (see Supplemental Information). Igfbp5 ISH was performed as previously described (Acharya et al., 2012) . The template for in vitro transcription of the ISH probe directed against the Igfbp5 3 0 UTR was generated by PCR with primers specified in Table S2 .
Statistical Analysis
Two-tailed Student's t tests were performed to calculate p values, unless specified otherwise. Error bars represent SDs. See also Extended Experimental Procedures.
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